Cargando…
Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Association for the Study of Intestinal Diseases
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934588/ https://www.ncbi.nlm.nih.gov/pubmed/29743828 http://dx.doi.org/10.5217/ir.2018.16.2.163 |
| _version_ | 1783320140325060608 |
|---|---|
| author | Jeon, Seong Ran |
| author_facet | Jeon, Seong Ran |
| author_sort | Jeon, Seong Ran |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5934588 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Korean Association for the Study of Intestinal Diseases |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59345882018-05-09 Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis? Jeon, Seong Ran Intest Res Editorial Korean Association for the Study of Intestinal Diseases 2018-04 2018-04-30 /pmc/articles/PMC5934588/ /pubmed/29743828 http://dx.doi.org/10.5217/ir.2018.16.2.163 Text en © Copyright 2018. Korean Association for the Study of Intestinal Diseases. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Jeon, Seong Ran Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis? |
| title | Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis? |
| title_full | Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis? |
| title_fullStr | Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis? |
| title_full_unstemmed | Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis? |
| title_short | Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis? |
| title_sort | is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934588/ https://www.ncbi.nlm.nih.gov/pubmed/29743828 http://dx.doi.org/10.5217/ir.2018.16.2.163 |
| work_keys_str_mv | AT jeonseongran isoncedailymultimatrixmesalazinetherapyeffectiveregardlessofthedoseinpatientswithmildtomoderateulcerativecolitis |